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The successful application of the Treponema
Pallidum Immobilization Test (TPI) (1) to the
serodiagnosis of syphilis and to the differentia-
tion between true and biological false positive re-
actions (BFP) has stimulated an accelerated
search for less costly and less complex treponemal
tests. Currently, there are at least seven modified
treponemal procedures under experimental study
and evaluation, of which, the several com-
plement.-fixation methods appear to be the most
promising as practical serodiagnostic tests for
routine laboratory use. Several obvious improve-
ments over the TPI test, in this respect, are as
follows: the treponemal complement-fixation test
can be learned easily and quickly by the average
laboratory technician; five to ten times as many
complement-fixation tests can be performed in
one day; the technical problems of strict adher-
ence to aseptic technique, chemical cleanliness,
treponemal survival and maintenance of rabbit
colonies are eliminated; and the cost of a comple-
ment-fixation test should be markedly less than
a TPI test.
The complement-fixation procedures which
have received the most attention in this country
are the Treponema Pallidum Complement-Fix-
ation Test (TPCF) described by Portnoy
and Magnuson in 1955—56 (2, 3) and the Reiter
Protein Complement-Fixation Test (RPCF)
which is an outgrowth of the fundamental studies
of the Italian serologists and dermatologists
during the period since 1941. Some of these stud-
ies have been summarized in the English language
by D'Alessandro et al (4, 5) and Pucinelli (6, 7).
In this laboratory, comparisons between the
TPI and TPCF tests have been made with speci-
mens from 394 patients with tentative clinical
diagnoses of syphilis or BFP reactions. In addi-
tion, a correlation between TPCF results and
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tentative clinical diagnoses and also the repro-
ducibility of TPCF results have been made. A
summary of these experiments constitutes the
major part of this publication.
In addition, this report includes preliminary
observations on the standardization of antigens
prepared from the nonpathogenic cultivatable
Reiter treponeme.
MATERIALS AND METHODS
Specimens: the serums used in this study were
prepared in this laboratory from blood specimens
submitted for TPI testing. Each serum used in
the complement-fixation tests had been stored
for periods of one week to four months at —10°C.
and each was reheated for 10 minutes at 56°C.;
and when necessary, the serum was clarified by
centrifugation before testing.
Antigens: TPCF antigens were obtained from
the Difco Laboratories or were prepared in our
own laboratory. These antigens were pre-
pared and standardized according to methods
described by Portnoy and Magnuson (2). The
only satisfactory Reiter (RPCF) antigen was
supplied by the Difco Laboratories.
Complement-Fixation Tests: the serological pro-
cedure of the TPCF and RPCF tests followed ex-
actly the modified one-fifth volume Kolnier
Complement-Fixation method using 13 exact
units of complement as described by Portnoy and
Magnuson (3). All tests were performed by the
same individual and read by him and by a second
person.
RESULTS
A. Comparison of TPI and TPCF tests on the
same specimens.
Sera were prepared from 394 blood specimens
collected from sero-positive patients whose status
in respect to syphilis was not definite. The results
of the TPI and TPCF tests on these specimens are
summarized in Table I.
The data in Table I show that the TPI test
was positive with 205 specimens (52%) and was
negative with 189 specimens (48%). The results
of the TPCF test were just reversed, in which 190
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TABLE I
Comparative TPI and TPCF Results with ,Speci-
mens from 894 Clinically Questionable Cases of
Syphilis
* Numerator indicates the number of specimens
giving the reactions indicated at the top of each
column. Denominator indicates the total number
of sera tested. Numbers in parentheses indicate
per cent.
specimens (48%) gave positive reactions and 204
specimens (52%) gave negative reactions. It is
of interest to note that the same reaction was
obtained with both tests on 363 of the 394 speci-
mens, an agreement of 92 per cent. One hundred
and eighty two sera were positive with both tests
and 181 were negative with both tests. The re-
suits of the two tests differed with 31 specimens,
a disagreement of eight per cent.
Since the specificity and sensitivity of the TPI
test have been shown to be quite high with serums
from clinically proven latent syphilities or non-
syphilitic individuals, then it might be concluded
that the differences in this experiment indicate
that the TPCF test is less sensitive than the TPI
test in patients with latent syphilis, some of whom
had been treated earlier for syphilis. This is sup-
ported by the data which show that of the 31
specimens with discordant results, three times
as many were TPI positive, TPCF negative as
were TPI negative, TPCF positive, 23 and 8 re-
spectively.
B. Correlation between clinical diagnosis and sero-
logic results.
To further compare the two technics, the re-
suits of the TPI and TPCF tests were correlated
with tentative clinical diagnosis of syphilis in 127
patients and of biologic false positive reaction
(BFP) in 108 patients. These data are summarized
in Table II.
It can be seen in Table II that the TPI test
was positive in 77 of the 127 suspected cases of
TABLE II
The Correlation between Clinical Diagnosis and
TPI and TPCF Reactions
Clinical Diagnosis—Syphilis Clinical Diagnosis—BFP
TPI+ TPCF+
77/127 69/127
(61) (54)
TPI— TPCF—
68/108 75/108
(63) (70)
syphilis (61%) and it was negative in 68 of the
108 suspected biologic false positive reactors
(63%). Thus, the results of the TPI test agreed
with clinical diagnosis in 145 of the total 235
specimens, an agreement of 62 per cent.
A similar comparison between clinical diagnosis
and TPCF results shows the following: 69 posi-
tive reactions in 127 suspected cases of syphilis
(54% agreement); 75 negative reactions in 108
presumed BFP reactors (70% correlation); an
agreement between TPCF results and diagnosis
in 144 of the 235 cases, 61 per cent.
There was little difference in the over-all
correlations between serologic activity and clini-
cal diagnosis when the two tests were compared.
However, the agreement between positive re-
actions and a diagnosis of syphilis was greater
with the TPI than with the TPCF test, and the
agreement between negative reactions and a
diagnosis of BFP reaction was greater with the
TPCF than with the TPI test. These findings
would suggest again that the TPCF test may be
somewhat less sensitive than the TPI test.
C. The reproducibility of TPCF tests.
To determine the reproducibility of the test
under standard conditions, studies were under-
taken in two ways. First duplicate tests were per-
formed simultaneously with aliquots of 88 TPCF
positive and negative serum specimens employing
two different standardized antigens; secondly, du-
plicate tests employing 61 TPCF positive and
negative serum specimens and the same antigen
were performed on different days, within a 14 day
period. The results of these studies are summa-
rized in Table III.
The data in Table III, in part I, show
that identical results were obtained with 82 of 88
serums (93%) that were tested simultaneously
with two different standard TPCF antigens; the
results of duplicate tests with six serums (7%)
disagreed. Perhaps the degrees of difference for
TPI+
205/394
(52)*
TPI+
TPCF+
182/304
(46)
TPI—
189/394
(48)
TN—
TPCF—
181/394
(46)
TPCF+
190/394
(48)
TPI+
TPCF—
23/394
(6)
TPCF—
204/394
(52)
TPI—
TPCF+
8/394
(2)
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these six sera, not shown in the table, are more
significant than the per cent of difference. Three
disagreements were between doubtful and nega-
tive reactions, two were between four plus and
one plus reactions, and one was between four
plus and negative reactions. The latter three
differences were of sufficient magnitude that
the serums were retested one or more times and
the same differences in reactivity were obtained.
The second experiment on reproducibility is
summarized in Table III, part II. Duplicate TP-
CF tests were performed at different times with
aliquots of 61 serums and one standard antigen.
Only three disagreements (5%) were noted, all of
which were differences between doubtful and neg-
ative reactions.
These findings suggest that under certain
circumstances the results of TPCF tests may not
be reproducible, not only in weakly reactive sera,
but also in strongly reactive specimens. Further,
that disagreements may be slightly more frequent
and of greater magnitude when duplicate tests
are performed with different antigens than when
the same antigen is employed at different times.
D. Preliminary studies with Reiter (RPCF) anti-
gen.
The serologic activities of one Reiter antigen
and two standardized TPCF antigens were de-
termined by a checkerboard titration of dilutions
of the antigens versus dilutions of a standard
TPCF positive serum.
The most interesting observation of this com-
parative titration may be summarized as follows:
employing a serum dilution of I to 40, the Reiter
antigen showed a titer of 1280+; TPCF antigen
No. 1, a titer of 40; and TPCF antigen No. 2,
a titer of 20. The Reiter antigen showed a zone
reaction in the area of antigen excess, i.e., no
TABLE III
Reproducibility of Duplicate TPCF Tests
I. Duplicate tests performed simultaneously
with aliquots of 88 specimens employing two
different standard antigens.
Agreement Disagreement
82/88 93) 6/88 (7)
II. Duplicate tests performed on different days,
with aliquots of the same serum specimens,
with the same standard antigen.
Agreement Disagreement
58/61 (95) 3/61 (5)
fixation of complement, in antigen dilutions 1 to
10 and 1 to 20. The results of the total titration
suggested that this Reiter antigen may have been
at least 25 times as active as the TPCF antigens.
This hypothesis was tested by examining five
negative sera, one strongly positive and six
weakly positive sera (all diluted 1—5) with the
two TPCF antigens at their standard titers of
1 to 12.5 and 1 to 8, and with the Reiter antigen
diluted 1 to 320 and 1 to 640. The Reiter dilutions
were from 25 to 80 times greater than the TPCF
dilutions. The results obtained are summarized
in Table IV.
The following interesting observations may be
noted in Table IV.
1. No non-specific reactions occurred with
either antigen and the five negative sera.
2. No difference of antigen sensitivity was
noted with the strongly positive serum.
3. Variations of antigen sensitivity were noted
when weakly positive sera were tested. For ex-
ample, reactions ranging from strongly positive
to negative were obtained with aliquots of one
serum that was tested with three different anti-
gens. There was as much variation in antigen
sensitivity between the two standard TPCF anti-
gens as there was between TPCF Antigen No. 1
and the Reiter antigen at a dilution of 1 to 320.
These data suggest that in spite of apparent simi-
larities between different standard TPCF anti-
gens, there may exist differences between them
that appear only when they are tested simul-
taneously with aliquots of the same weakly
positive sera.
The results obtained in this study corroborate
TABLE IV
Comparative Specificity and Sensitivity of Reiter
and TPCF Antigens
TPI Tested Sera
Reiter Antigen
Diluted
TPCF
No. I
Diluted
TPCF
No. 2
Diluted
1—320 1—640 1—12.5 1—8
5 Negative
1 Positive
6 Weakly
positive
—
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other unpublished data accumulated in our early
efforts to produce and standardize TPCF anti-
gens, namely, that the current method of stand-
ardizing antigens for treponemal complement-
fixation tests on the basis of a serologic titration
with one pooled positive serum and one pooled
negative serum is unsatisfactory and unrelinbie.
A supplementary step should include the simul-
taneous testing of several weakly positive and
negative individual human serum specimens.
SUMMARY
1. An evaluation has been made of the
Treponema Pallidum Complement-Fixation
(TPCF) test using the Treponema Pallidum Im-
mobilization (TPI) test as a control.
2. In comparative studies with the two pro-
cedures, employing aliquots of serum specimens
from 394 cases of possible latent syphilis or
biologic false positive reactors, 92 per cent agree-
ment was obtained. The nature of the disagree-
ments indicates that the TPCF test is less
sensitive than the TPI test for specimens ob-
tained from the clinical groups described.
3. Under two different experimental con-
ditions, the TPCF test results were reproducible
in 93 and 95 per cent of instances of duplicate
testing. Reproducibility of results was less satis-
factory if aliquots of sera were tested simulta-
neously with two different antigens than if such
aliquots were tested on different days with the
same antigen.
4. Comparative standardization of antigens
prepared from the cultivatable Reiter treponeme
and from the pathogenic Nichols strain of
Treponema pallidum indicated that the Reiter
antigen is probably much more active serologi-
cally than the latter antigen. Supplementary
steps in the standardization of the treponemal
complement-fixation antigens are suggested.
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